ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer

Clinical trial NCT00394082 · COMPLETED

Trial details

NCT number: NCT00394082
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2006-06-01
Primary completion: 2009-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.